Delivery Order SPE2DB20D3103-SPE2DB24FN0N9
- Not listed
- This federal contract award, valued at $4,162.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product, with a performance period extending through April 2025. The contract is a delivery order and is priced on a firm-fixed-price basis. It is not designated as a set-aside contract, indicating open competition....
- This federal contract award, valued at $1,461.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product. This award is not designated as a set-aside contract. The contract has an ultimate completion date of December 18, 2024 and was awarded on December 17, 2024. AmerisourceBergen Drug Corp,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of APREPITANT 80 mg capsules. The contract has a ceiling value of $1,039.50 and a completion date of May 23, 2025. The award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This IDC enables Amerisourcebergen to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $2,788.48, is for the supply of APREPITANT 40 MG CAPSULE UD 5S, a type of prescription medication. The contract has a firm fixed price pricing type and a completion date of November 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- This federal contract award, valued at $7,093.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4567873449 - APREPITANT 40 MG CAPSULE UD 5S, and has a firm fixed price pricing type with an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,377.56, is a delivery order for the supply of 4567772479 APREPITANT 40 MG CAPSULE UD 5S. The contract has an ultimate completion date of April 3, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp, the prime contractor, has an extensive history of federal contract awards,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $7,008.15, with a Firm Fixed Price pricing type. The award is for the provision of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product. The contract has an Ultimate Completion Date of June 12, 2025. Amerisourcebergen Drug Corp is the prime contractor on this award, which is...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,464.58 firm fixed-price contract is for the delivery of APREPITANT 80 MG CAPSULE UD 6S, a specialty pharmaceutical product, with a completion date of October 23, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $12,517.22 firm-fixed-price delivery order is for the supply of 4562584778 APREPITANT 40 MG CAPSULE UD 5S, with an ultimate completion date of October 25, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite...
- This federal contract award, valued at $2,750.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of 4562217703 APREPITANT 80 MG CAPSULE UD 6S, a pharmaceutical product. The contract has an ultimate completion date of September 19, 2023 and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN0N9Delivery Order
This federal contract award, valued at $1,385.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of APREPITANT 80 MG CAPSULE UU 2S, a pharmaceutical product, with a completion date of March 18, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs worldwide. The contract does not have a set-aside designation, indicating it was awarded through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 3/15/24 |